Skip to content Skip to navigation

Popular Alzheimer’s drug now available in generic patch

September 4, 2015
by Pamela Tabar, Editor-in-Chief
| Reprints

The first generic version of Exelon (rivastigmine tartrate), a popular drug for treating mild to moderate dementia, appeared on the U.S. market this week, giving providers and seniors a more economical alternative to the branded drug. Rivastigmine is used to treat the cognitive issues associated with Alzheimer’s disease and Parkinson’s disease.

Swiss drug manufacturer Acino launched the drug in a transdermal patch form and in three doseage strengths.  It is being sold in the United States by Acino’s licensing partner, Alvogen.

The generic rivastigmine patch has been used in the UK and parts of Europe for several years.

Memory Care Forum - Focus: Memory Care

Get the latest information on Memory Care, and attend other valuable sessions at this two-day event making education on the research, innovations, and program approaches to memory care a priority.

Philadelphia, May 23-24   |   San Diego, September 22-23